A RANDOMIZED, OPEN-LABEL STUDY TO COMPARE THE SAFETY AND EFFICACY OF CYCLOSPORINE (CSA) DOSE REDUCTION WITH CSA ELIMINATION IN DE NOVO RENAL ALLOGRAFT PATIENTS RECEIVING SIROLIMUS

2008 ◽  
Vol 86 (Supplement) ◽  
pp. 157
Author(s):  
H Tedesco-Silva ◽  
J M. Pestana ◽  
F Alfieri ◽  
S See-Tai
Keyword(s):  
Dose Reduction ◽  
Renal Allograft ◽  
De Novo ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Safety And Efficacy

A Randomized, Open-Label Study of Sirolimus Versus Cyclosporine in Primary De Novo Renal Allograft Recipients

2013 ◽  
Vol 95 (10) ◽  
pp. 1233-1241 ◽  
Author(s):  
Stuart M. Flechner ◽  
Alihan Gurkan ◽  
Anders Hartmann ◽  
Christophe M. Legendre ◽  
Graeme R. Russ ◽  
...  
Keyword(s):  
Renal Allograft ◽  
De Novo ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals Safety and Efficacy of Oral Human Parathyroid Hormone (1‐34) in Hypoparathyroidism: An Open‐Label Study

2021 ◽  
Author(s):  
Sofia Ish‐Shalom ◽  
Yoseph Caraco ◽  
Nariman Saba Khazen ◽  
Michal Gershinsky ◽  
Auryan Szalat ◽  
...  
Keyword(s):  
Parathyroid Hormone ◽  
Human Parathyroid Hormone ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Safety And Efficacy
Sign in / Sign up

Export Citation Format

Share Document